• Bristol Myers Squibb average debt/equity ratio for 2023 was 1.13, a 1.74% increase from 2022.
• Bristol Myers Squibb average debt/equity ratio for 2022 was 1.15, a 2.68% decline from 2021.
• Bristol Myers Squibb average debt/equity ratio for 2021 was 1.12, a 17.89% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.